Champions Oncology
$7.029876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.22 (-3.04%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours
Why Robinhood?
You can buy or sell CSBR and other stocks, options, ETFs, and crypto commission-free!
About CSBR
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Read More It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Employees
115
Headquarters
Hackensack, New Jersey
Founded
1985
Market Cap
84.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
41.24K
High Today
$7.19
Low Today
$6.90
Open Price
$7.16
Volume
10.06K
52 Week High
$11.94
52 Week Low
$4.98
Collections
CSBR Earnings
-$0.05
-$0.02
$0.02
$0.05
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Mar 16, After Hours
People Also Bought
Qutoutiao
3,786
$5.60
+3.32%NIO
130,735
$3.94
+4.51%Pyxus International
2,073
$4.35
-2.90%TherapeuticsMD
12,916
$2.41
-2.82%China Internet Nationwide
1,705
$0.7276
-1.68%Oragenics
47,652
$0.5449
+3.51%Uxin
4,049
$2.00
-8.68%ProShares Ultra VIX Short...
5,797
$10.83
+1.31%Zynerba Pharmaceuticals
23,128
$4.87
+8.46%AVEO Pharmaceuticals
12,447
$0.58
+3.78%India Globalization Capital
57,666
$0.5883
+1.64%Amarin
16,082